Clinical Trial Update: Talampanel in Treating Patients With Recurrent High-Grade Glioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of talampanel for recurrent high-grade glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Drugs mentioned

• Talampanel (talampanel)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED